ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Scope & Guideline

Elevating Standards in Antimicrobial Research and Practice

Introduction

Welcome to the ANTIMICROBIAL AGENTS AND CHEMOTHERAPY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0066-4804
PublisherAMER SOC MICROBIOLOGY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1963 to 1970, from 1972 to 2024
AbbreviationANTIMICROB AGENTS CH / Antimicrob. Agents Chemother.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1752 N ST NW, WASHINGTON, DC 20036-2904

Aims and Scopes

The journal 'Antimicrobial Agents and Chemotherapy' focuses on advancing the understanding of antimicrobial agents and their applications in treating infectious diseases. It emphasizes research that spans the microbiological, pharmacological, and clinical dimensions, providing a platform for innovative studies that address contemporary challenges in antimicrobial therapy.
  1. Antimicrobial Resistance Mechanisms:
    Research on the mechanisms by which bacteria and fungi develop resistance to various antimicrobial agents, including β-lactams, fluoroquinolones, and antifungals.
  2. Clinical Pharmacokinetics and Pharmacodynamics:
    Studies that analyze the pharmacokinetics and pharmacodynamics of antimicrobial agents, aiming to optimize dosing regimens and improve therapeutic outcomes.
  3. Novel Antimicrobial Agents:
    Development and evaluation of new antimicrobial compounds, including novel antibiotics, antivirals, and antifungals, targeting resistant pathogens.
  4. In Vitro and In Vivo Efficacy Studies:
    Evaluation of antimicrobial efficacy through laboratory and clinical studies, including animal models, to assess the effectiveness of new and existing therapies.
  5. Epidemiological Surveillance:
    Investigations into the epidemiology of infectious diseases, including the prevalence and spread of resistant strains in various populations.
  6. Innovative Therapeutic Approaches:
    Research on combination therapies, phage therapy, and other novel strategies to enhance the efficacy of existing antimicrobial treatments.
Recent publications reflect dynamic shifts in the research landscape of antimicrobial agents, highlighting emerging themes that are gaining increased attention. These trends indicate the evolving nature of infectious disease challenges and the response of the scientific community.
  1. Antimicrobial Stewardship:
    Growing focus on antimicrobial stewardship programs aimed at optimizing the use of antimicrobials to combat resistance and improve patient outcomes.
  2. Phage Therapy:
    Increased interest in bacteriophage therapy as a viable alternative or adjunct to antibiotics, particularly against multidrug-resistant bacteria.
  3. Machine Learning and AI in Drug Development:
    Application of machine learning and artificial intelligence techniques to predict antimicrobial efficacy, optimize dosing regimens, and identify novel drug candidates.
  4. Global Surveillance of Resistance Patterns:
    Enhanced efforts in global surveillance studies to track antimicrobial resistance patterns, particularly in response to the COVID-19 pandemic.
  5. Pharmacogenomics:
    Emerging research into pharmacogenomic factors affecting antimicrobial therapy, tailoring treatments based on individual genetic profiles.
  6. Combination Therapy Approaches:
    A trend towards exploring combination therapies that synergize multiple agents to enhance efficacy against resistant pathogens.

Declining or Waning

While the journal continues to cover a wide range of topics in antimicrobial research, certain areas have seen a decline in publication frequency or interest. This may indicate shifting research priorities or the saturation of previously hot topics.
  1. Traditional Antibiotics:
    Research focusing on the efficacy of traditional antibiotics has diminished as the field shifts towards exploring novel agents and combination therapies.
  2. Single-Agent Studies:
    There has been a noticeable reduction in studies investigating the effectiveness of single-agent treatments, as the focus moves towards combination therapies to combat resistance.
  3. Non-Pharmacological Interventions:
    Studies examining non-pharmacological interventions (e.g., infection control measures) in antimicrobial therapy have decreased, likely due to a greater emphasis on drug development.
  4. Antifungal Resistance Mechanisms:
    While antifungal resistance remains a concern, the volume of research specifically addressing resistance mechanisms has seen a relative decline compared to the surge in studies on bacterial resistance.

Similar Journals

Jundishapur Journal of Microbiology

Advancing microbial knowledge for a healthier tomorrow.
Publisher: BRIEFLANDISSN: 2008-3645Frequency: 12 issues/year

Welcome to the Jundishapur Journal of Microbiology, a peer-reviewed publication dedicated to advancing the field of microbiology. Published by BRIEFLAND, this journal focuses on key areas such as infectious diseases and medical microbiology, offering a platform for researchers to share their findings from 2009 to 2024. Despite its current positioning in Quartile 4 across various categories in 2023, the journal provides a valuable resource for budding scientists and established professionals alike, contributing to the growing body of knowledge in these critical areas. While it is not an open-access journal, the Jundishapur Journal prioritizes the dissemination of research in the Netherlands, facilitating a deeper understanding of microbial science and its implications for public health. Join a community of innovators committed to exploring both emerging and established themes in microbiology.

Pathogens

Innovating Solutions for Tomorrow's Health Challenges
Publisher: MDPIISSN: Frequency: 12 issues/year

Pathogens is a leading open-access journal published by MDPI since 2012, dedicated to advancing the understanding of infectious agents and their interactions with hosts in the fields of immunology, microbiology, and molecular biology. Based in Switzerland, this journal plays a crucial role in disseminating high-quality research that spans from fundamental studies of pathogen biology to the implications for global health and disease management. With a commendable impact factor and prestigious Q2 rankings across multiple categories—including Immunology and Microbiology—Pathogens ensures visibility and accessibility for groundbreaking findings. The journal embraces the ethos of open access, allowing researchers, professionals, and students to access critical research anytime, facilitating a collaborative and innovative academic environment. By bridging the gap between research and application, Pathogens is instrumental in shaping the future of infectious disease research and management.

Emerging Microbes & Infections

Elevating global health through open access research.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.

INFECTION

Empowering Healthcare through Cutting-edge Discoveries
Publisher: SPRINGER HEIDELBERGISSN: 0300-8126Frequency: 6 issues/year

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.

JAC-Antimicrobial Resistance

Bridging Knowledge Gaps in Antimicrobial Resistance
Publisher: OXFORD UNIV PRESSISSN: Frequency: 4 issues/year

JAC-Antimicrobial Resistance, published by Oxford University Press, is a pioneering open-access journal that has been contributing to the vital discourse on antimicrobial resistance since its inception in 2019. With an E-ISSN of 2632-1823, the journal operates out of the United Kingdom and is dedicated to advancing our understanding of antimicrobial resistance mechanisms, impacts, and solutions across a variety of related fields including Immunology, Infectious Diseases, and Microbiology. The journal currently ranks in the Q2 category for these disciplines, highlighting its growing impact and relevance within the academic community. Researchers, practitioners, and students alike will find a treasure trove of high-quality, peer-reviewed articles that are freely accessible, aligning with contemporary trends in scientific publishing. As the world grapples with the rising threat of antimicrobial resistance, JAC-Antimicrobial Resistance stands as an essential resource for those seeking to stay at the forefront of this critical field.

Infection and Chemotherapy

Exploring Innovations in Infectious Disease Treatment
Publisher: KOREAN SOC ANTIMICROBIAL THERAPYISSN: 2093-2340Frequency: 4 issues/year

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

Exploring the Frontiers of Food Microbiology
Publisher: ELSEVIERISSN: 0168-1605Frequency: 24 issues/year

INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY is a leading journal in the field of food safety and microbiology, published by Elsevier. With an impressive impact factor and a distinguished position, it ranks in the top quartile for both Food Science and Medicine, as well as holding a strong presence in Microbiology and Safety, Risk, Reliability, and Quality categories. The journal provides a vital platform for researchers, professionals, and students to disseminate and discuss innovative research findings and applications that address the complexities of food microbiology. Operating from its headquarters in the Netherlands, this journal not only facilitates access to high-quality scholarly articles but also encourages the development of interdisciplinary approaches to tackle current challenges in food safety and public health. Since its inception in 1984, the journal has continually evolved, ensuring that it remains at the forefront of scientific inquiry, making it a crucial resource for anyone engaged in the food sciences.

Reviews and Research in Medical Microbiology

Pioneering Insights into Pathogens and Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2770-3150Frequency: 4 issues/year

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.

International Journal of Antimicrobial Agents

Connecting Researchers and Clinicians in the Battle Against Infections
Publisher: ELSEVIERISSN: 0924-8579Frequency: 12 issues/year

International Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.

RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY

Bridging Theory and Practice in Bioorganic Science
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1068-1620Frequency: 7 issues/year

Russian Journal of Bioorganic Chemistry (ISSN: 1068-1620, E-ISSN: 1608-330X), published by MAIK Nauka/Interperiodica/Springer, serves as a vital resource for researchers and professionals in the fields of bioorganic chemistry, biochemistry, and organic chemistry. With a focus on the integration of organic chemistry principles with biological processes, this journal aims to disseminate significant findings and advancements from both theoretical and practical perspectives. Although currently not open access, the journal retains a dedication to high-quality, peer-reviewed content, contributing to its reputation within the academic community. The 2023 Scopus rankings position it within the Q4 category for both biochemistry and organic chemistry, indicating its critical niche within these disciplines amid a competitive landscape. Since its inception in 1996, the journal has continued to evolve, providing enriching insights and fostering collaborations among scholars and practitioners alike, with publication converging up to the year 2024. By exploring complex biomolecular interactions and the synthesis of biologically relevant compounds, the Russian Journal of Bioorganic Chemistry remains a significant platform for advancing knowledge and innovation in the life sciences.